Initiative Includes Milestone-Based Inventory Purchase Commitments During Q1 and Q2, 2025Toronto, Ontario--(Newsfile Corp. - December 18, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX)...
Inretio presents initial clinical trial results at prestigious BRAIN Conference 2024 in London.Toronto, Ontario--(Newsfile Corp. - December 11, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE:...
Distributors' medical partner networks impressed with Venowave device, speed of Medicare/Medicaid processing and prepare roadmaps to drive salesToronto, Ontario--(Newsfile Corp. - December 5, 2024) - Therma...
Toronto, Ontario--(Newsfile Corp. - November 18, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF), a leading developer and investment partner in advanced diagnostic and medical device technologies,...
Toronto, Ontario--(Newsfile Corp. - November 11, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma Bright" or the "Company"), a developer and investment partner in a wide range of leading-edge,...
InStatin to secure exclusive worldwide licensing agreement of InVixa's inhaled statin solution to prevent and treat acute lung diseaseToronto, Ontario--(Newsfile Corp. - October 28, 2024) - Therma Bright...
Toronto, Ontario--(Newsfile Corp. - October 18, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX) ("Therma Bright" or the "Company"), a developer and investment partner in a wide range...
Quantify Medical Sees Initial Success with Venowave VW5 Sales and Medicare/Medicaid Reimbursement TestTherma Bright Closes First Tranche of Non-Brokered Concurrent Private Placement for CAD $174,900Toronto,...
Will be conducting a non-brokered listed issuer financing exemption (LIFE) private placement of up to ...
LIFE Financing and Concurrent Private Placement to Include Common Shares Only and no WarrantsToronto, Ontario--(Newsfile Corp. - September 27, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma...